Review article: yeast as probiotics –Saccharomyces boulardii
Open Access
- 19 July 2007
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 26 (6), 767-778
- https://doi.org/10.1111/j.1365-2036.2007.03442.x
Abstract
Summary Background Probiotics are defined as live micro-organisms which confer a health benefit on the host. Although most probiotics are bacteria, one strain of yeast, Saccharomyces boulardii, has been found to be an effective probiotic in double-blind clinical studies. Aims To compare the main properties that differentiates yeast from bacteria and to review the properties of S. boulardii explaining its potential benefits as a probiotic. Methods The PubMed and Medline databases were searched using the keywords ‘probiotics’, ‘yeast’, ‘antibiotic associated diarrhea’, ‘Saccharomyces boulardii’,‘bacterial diarrhea’ and ‘inflammatory bowel disease’ in various combinations. Results Several clinical studies have been conducted with S. boulardii in the treatment and prevention of various forms of diarrhoea. Promising research perspectives have been opened in terms of maintenance treatment of inflammatory bowel diseases. The mechanism of S. boulardii’s action has been partially elucidated. Conclusion Saccharomyces boulardii is a strain of yeast which has been extensively studied for its probiotic effects. The clinical activity of S. boulardii is especially relevant to antibiotic-associated diarrhoea and recurrent Clostridium difficile intestinal infections. Experimental studies clearly demonstrate that S. boulardii has specific probiotic properties, and recent data has opened the door for new therapeutic uses of this yeast as an ‘immunobiotic’.Keywords
This publication has 65 references indexed in Scilit:
- Genotypic and Physiological Characterization of Saccharomyces boulardii , the Probiotic Strain of Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2007
- Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo‐controlled studyActa Paediatrica, 2007
- Saccharomyces boulardii Inhibits Inflammatory Bowel Disease by Trapping T Cells in Mesenteric Lymph NodesGastroenterology, 2006
- Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trialsThe Journal of Pediatrics, 2006
- Effects of Saccharomyces boulardii in children with acute diarrhoeaActa Paediatrica, 2005
- Molecular and physiological comparisons betweenSaccharomyces cerevisiaeandSaccharomyces boulardiiCanadian Journal of Microbiology, 2004
- Reflections on the classification of yeasts for different end-users in biotechnology, ecology, and medicineInternational Microbiology, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Adherence of Escherichia coli serogroup 0 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardiiMycoses, 1999
- Immunological and Trophical Effects of Saccharomycesboulardii on the Small Intestine in Healthy Human VolunteersDigestion, 1996